Ana Fernandez Gallego

Ana Fernandez Gallego

Auto-generated profile, based on publicly available information

Ana Fernandez Gallego

The Royal (Dick) School of Veterinary Studies and the Roslin Institute, Easter Bush Campus, The University of Edinburgh , Midlothian

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2020 in Journal of Feline Medicine and Surgery
Verified
Journal Article
Closed access
PDF file
AFAna Fernandez-Gallego
Ana Fernandez-Gallego
LBLuis Feo Bernabe
Luis Feo Bernabe
ADAnabel Dalmau
Anabel Dalmau
DEDiego Esteban-Saltiveri
Diego Esteban-Saltiveri
AFArtur Font
Artur Font
MBMar Bardagí
Mar Bardagí
Objectives: Leishmaniosis is a vector-borne disease and in European countries is caused by Leishmania infantum . Cats are considered secondary reservoirs of the infection in endemic areas. The objective of this retrospective study is to describe the clinical findings, diagnosis, treatment and outcome of feline leishmaniosis (FeL) in 16 cats in Spain. Methods: Medical records of cats diagnosed with leishmaniosis were retrospectively reviewed for cases that met the following inclusion criteria: identification of Leishmania organisms and/or DNA on cytological and/or histological specimens and/or a high anti- Leishmania antibody titre, compatible clinical findings and pathological abnormalities. Results: Sixteen cats met the inclusion criteria, all of which were living in areas endemic for canine leishmaniosis. Systemic signs were present in 11 cases (68.8%). The most common clinical signs on presentation included cutaneous lesions in 12 cats (75%), ocular disease in six cats (37.5%) and anorexia in six cats (37.5%). A polyclonal gammopathy was noted in 12 cats (85.7%). Non-regenerative anaemia and renal abnormalities were present in six (37.5%) and five patients (31.3%), respectively. In nine cats (56.3%), immunosuppressive conditions/comorbidities were identified. The diagnosis was made in eight of the cats (50%) by cytology, but a combination of diagnostic tests was needed for definitive diagnosis in the remaining patients. Twelve cats (75%) were treated specifically for leishmaniosis. Five of the 12 cats (41.7%) did not improve with treatment. The median survival time in the group of patients treated specifically for leishmaniosis was 17 months. Median survival of patients treated with concomitant diseases was 13 months vs 41 months in those without, although this was not statistically significant ( P = 0.557). Conclusions and relevance: Presentation of FeL appears to be similar to canine leishmaniosis but with some specific features: ulcerative and nodular skin lesions are the predominant cutaneous signs; cats with immunosuppressive conditions or coexisting diseases were more commonly present than typically seen in dogs (mainly feline immunodeficiency virus). A combination of diagnostic tests may be needed for definitive diagnosis.

3 February 2022 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
AGAna Fernandez Gallego
Ana Fernandez Gallego
AGAdam G. Gow
Adam G. Gow
ABAlisdair M. Boag
Alisdair M. Boag
Background: Resting cortisol concentrations are routinely measured in dogs with chronic gastrointestinal signs to rule out hypoadrenocorticism based on a concentration >2 μg/dL (>55 nmol/L). Hypothesis/Objectives: To assess the cross-sectional prevalence of hypoadrenocorticism in a group of dogs with chronic gastrointestinal signs presented to a referral internal medicine service. Animals: Two-hundred and eighty-two client-owned dogs with chronic gastrointestinal signs and with resting cortisol concentration testing performed. Methods: Retrospective review of medical records (final diagnosis, resting cortisol concentration, and adenocorticotropic hormone [ACTH] stimulation test results) of a referral population of dogs between May 2013 and September 2017. Results: Resting cortisol concentration was <2 μg/dL (<55 nmol/L) in 79 patients (28%). Repeated resting cortisol concentration measurements were performed in 28 dogs, and in 8, resting cortisol concentrations remained <2 μg/dL (<55 nmol/L). Post-ACTH cortisol concentration was <2 μg/dL (<55 nmol/L) in 1 dog, consistent with a diagnosis of hypoadrenocorticism and giving a prevalence estimate of hypoadrenocorticism in this population of dogs of 0.3% (95% confidence interval [95CI], 0.03-1.5%). In 19 dogs with an initial resting cortisol concentration <2 μg/dL (2 μg/dL (>55 nmol/L). Overall, the most common diagnosis was chronic primary inflammatory enteropathy (176/282, 62.4%), followed by extragastrointestinal neoplasia (17/282, 6%), protein-losing enteropathy, pancreatitis and megaesophagus (10/282, 3.5% each). Conclusions and Clinical Importance: Although dogs with hypoadrenocorticism can present with chronic gastrointestinal signs, it was the final diagnosis in only 1 of 282 dogs presenting to a referral internal medicine service for signs of chronic enteropathy. Repeated resting cortisol concentration may be considered as a test to try and exclude hypoadrenocorticism.

11 October 2020 in Journal of Comparative Pathology
Verified
Journal Article
Open access
AFAna Fernández-Gallego
Ana Fernández-Gallego
JDJorge Del-Pozo
Jorge Del-Pozo
ABAlisdair Boag
Alisdair Boag
SMScott Maxwell
Scott Maxwell
JPJorge Pérez-Acino
Jorge Pérez-Acino
Xanthogranuloma of the sellar region has been reported in both humans and animals. The lesion is rare, and its aetiology and pathogenesis are not fully understood. The association of sellar xanthogranuloma with an adenoma, known as xanthogranulomatous pituitary adenoma (XPA), is an extremely rare condition in humans and is usually associated with anterior pituitary insufficiencies, headache, vomiting and visual deficits. We present the first report of XPA in an animal. A 7-year-old male neutered Labrador Retriever was presented for investigation of progressive lethargy, vomiting and hyporexia, having been previously diagnosed with chronic kidney disease, pituitary-dependent hyperadrenocorticism and hypoparathyroidism. The dog was euthanized due to lack of response to medical treatment and post-mortem examination revealed XPA. Although rare, xanthogranulomatous lesions should be considered in patients with pituitary disease.

1 November 2024 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
AGAna Fernandez Gallego
Ana Fernandez Gallego
CBCraig Robert Breheny
Craig Robert Breheny
AGAdam G. Gow
Adam G. Gow
ABAlisdair M. Boag
Alisdair M. Boag
Background: The relationship between collapse and a diagnosis of hypoadrenocorticism is not well understood in dogs. Hypothesis: To assess the prevalence of episodes of collapse in dogs screened for hypoadrenocorticism, and to assess the prevalence of confirmed hypoadrenocorticism in dogs presenting with reported collapse. Animals: Seventy-three client-owned dogs with resting cortisol concentrations were measured and presented to a University teaching hospital for collapse. Methods: Retrospective review of medical records of dogs at a single center. Results: The prevalence of episodes of collapse in dogs that had a resting cortisol measurement was 73/856 (8.5%; 95% confidence interval [95% CI], 6.7%-10.6%). Resting cortisol concentration was <2 μg/dL (<55 nmol/L) in 19 dogs. Cortisol concentration after ACTH stimulation was <2 μg/dL (<55 nmol/L) in 1 of the 73 dogs in this cohort, consistent with a diagnosis of hypoadrenocorticism, giving a prevalence estimate of hypoadrenocorticism of 1.3% (95% CI, 0.15%-6.2%). In 8 dogs with an initial resting cortisol concentration <2 μg/dL (2 μg/dL (>55 nmol/L). The most common diagnosis was vasovagal syncope (10/73), followed by sick sinus syndrome and third-degree atrioventricular block (2/73). The final diagnosis was unknown in 24/73 dogs. Conclusions and Clinical Importance: Hypoadrenocorticism was the final diagnosis in 1 of 73 dogs presented to a teaching hospital either in a collapsed state or with a previous history of episodes of collapse. No dog presenting as cardiovascularly stable for intermittent collapse was found to have hypoadrenocorticism.

1 November 2026 in American Journal of Veterinary Research
Verified
Journal Article
Open access
AGAna Fernandez Gallego
Ana Fernandez Gallego
JMJair Marques
Jair Marques
Dominic KURIANDominic KURIAN
Dominic KURIAN
FDFederico Diez
Federico Diez
RMRichard Mellanby
Richard Mellanby
KFKiterie M. E. Faller
Kiterie M. E. Faller
Objective: To identify specific metabolomic changes in dogs showing signs of hepatic encephalopathy (HE) compared to those not showing obvious neurological signs and to follow these changes following medical treatment. Methods: In this prospective observational study, we recruited 10 client-owned dogs diagnosed with congenital portosystemic shunt (from March 2021 through October 2022). The sera of dogs with or without signs of HE at the time of diagnosis of congenital portosystemic shunt and following medical treatment for more than 4 weeks were analyzed by UPLC-MS. Results: Dogs showing signs of HE at the time of diagnosis (n = 6) had significantly lower serum concentrations of taurine (fold change [FC], 0.44), creatine (FC, 0.32), and guanine (FC, 0.45) and higher serum concentrations of 3-hydroxybenzaldehyde (FC, 2.51) than their counterparts not showing signs of HE (4). A marked albeit nonsignificant decrease in serum stearate concentrations was also observed in the HE group (FC, 0.12). Following medical treatment, which improved neurological signs, the concentrations of these metabolites, particularly taurine, normalized to concentrations similar to the non-HE group. Conclusions: Dogs with HE exhibit a different serum metabolomic profile compared to dogs without signs of HE. The main changes are suggesting disturbances in mitochondrial homeostasis in dogs suffering from HE. Clinical Relevance: Supporting mitochondrial function could form the basis of new therapeutic strategies in HE and merits further investigations in future studies.